Lozada, Reynaldo T.
HRN: 11-63-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/09/2025
12/16/2025
IV
4.5g
Q8h
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes